About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL)

NCT02708732·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Hoffmann-La Roche

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Adults greater than or equal to (\>/=) 18 years of age
Diagnosis of DLBCL and currently in first remission
Prior drug treatment for DLBCL

You may not be if

Receiving active treatment for DLBCL
Relapsed following any treatment for DLBCL

The record

StatusCompleted

PhaseNo phase

Taking part91

StartedMay 2016

UpdatedApr 20, 2017

Conditions

Diffuse Large B-Cell Lymphoma

Where1

PH Associates - an OPen Health Company
Marlow, United Kingdom

Clareo Health | Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL)